Navigation Links
K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
Date:6/17/2011

All statements that address expectations or projections about the future, including without limitation, statements about product development, product launches, regulatory approvals, governmental and regulatory actions and proceedings, market position, acquisitions, sale of assets, revenues, expenditures, resumption of manufacturing and distribution of products and the impact of the recall and suspension of shipments on revenues, and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the PSLRA's "safe harbor" provisions, the Company provides the following cautionary statements identifying important economic, competitive, political, regulatory and technological factors, among others, that could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following:

(1) the Company's ability to continue as a going concern;

(2) completion of the transactions contemplated by the definitive asset purchase agreement for the sale of the Company's generic products business and Nesher subsidiary and compliance by the Company and the buyer with their respective related contractual obligations;  

(3) the impact of competitive, commercial, payor, governmental (including Medicaid program), physician, patient, public or political responses and reactions, and responses and reactions by medical professional associations and advocacy groups, to the Company's sales, marketing, product pricing, product access and strategic efforts with respect to Makena™, and its other products, including introduction or potential introduction of generic or competing products, or competition from unapproved therapies or compounded drugs, against p
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Par Pharmaceutical Reports Second Quarter 2008 Results
3. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
4. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
5. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
6. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
7. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
8. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
9. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
10. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
11. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (PRWEB) July 23, 2014 OncLive® ... Cancer Center has joined its Strategic Alliance Partnership ... Alliance Partnership program, UNC Lineberger will have the ... raise awareness of its cutting-edge research initiatives, community-directed ... UNC Lineberger will work with OncLive to educate ...
(Date:7/23/2014)... 23, 2014 Adult stem cells ... are biological, but not magical. However, many ... treat them as if they were magical. , ... studies that constitute “stem cell tourism,” are evaluating ... to developing new regenerative medicine therapies. In reality, ...
(Date:7/22/2014)... NJ (PR Web) July 21, 2014 (PRWEB) July ... Center for Biomaterials, at Rutgers University. , ... information and ideas across the full spectrum of ... on selected research and development topics that represent ... Activities have been programmed to:, ...
(Date:7/22/2014)... 22, 2014 Even within a phylum so full of ... among other arthropods for its cruelty -- at least to ... the fly is a most predatory sort of parasite. It ... a smear of larvae, and leaves its wicked brood to ... , None of this would be possible without the fly,s ...
Breaking Biology Technology:OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 2The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 3The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 4The Adult Stem Cell Technology Center, LLC Continues to Develop Technologies for Homologous Adult Stem Cell Therapies and Drug Development 5The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4
... Inc. (Nasdaq: IDIX ) announced today that management ... programs at the Canaccord Adams Hepatitis C Conference on Tuesday, ... Barclay New York Hotel in New York City.The live and ... of Events" in the Idenix Investor Center at ...
... Agent to Find Partner to Co-Develop Company,s Chinese ... VEGAS, April 3 ... "Company") is pleased to announce that it ... an international marketing organization headquartered in New Jersey ...
... ChromaDex Corporation, (OTC Bulletin Board: CDXC) a ... today announced financial results for the 2008 Fiscal ... with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ... stockholders of $0.07 per share for the twelve ...
Cached Biology Technology:Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier 2ChromaDex Announces 2008 Year End Financial Results 2ChromaDex Announces 2008 Year End Financial Results 3
(Date:7/23/2014)... International Journal of Fuzzy Systems ( IJFS ... Association (TFSA). The cooperation will allow the journal to ... research., The International Journal of Fuzzy Systems ... the theory, design and application of fuzzy systems, soft ... from hardware to software. Launched in 1999, the quarterly ...
(Date:7/23/2014)... principal bacteria that cause dental caries, has increased ... possibly coinciding with dietary change linked to the ... a study by researchers from the Universitat Autnoma ... Genmica para la Biodiversidad (National Laboratory of Genomics ... time, have sequenced genetic material from this bacterium ...
(Date:7/23/2014)... equipment, trained personnel, and detection dogs to safeguard ... A revolutionary new electronic chip with nano-sized chemical ... easier. , The groundbreaking nanotechnology-inspired sensor, devised by ... School of Chemistry and Center for Nanoscience and ... picks up the scent of explosives molecules better ...
Breaking Biology News(10 mins):Ancient genetic material from caries bacterium obtained for the first time 2Nano-sized chip "sniffs out" explosives far better than trained dogs 2
... identified a specific class of pharmaceutical drugs that could ... Death Syndrome (SIDS), because their mothers smoked during pregnancy. ... the fetus to nicotine results in the inability to ... in a higher incidence of SIDS. In the ...
... recent years, obesity has taken on epidemic proportions in ... death and rising health care costs. According to Centers ... quarter of all American adults and more than 15 ... While recent research advances and treatment methods ...
... collaboration research carried out by the teams of Jordi ... and ngel Raya, Centre for Regenerative Medicine of Barcelona ... and Technological Research (CIEMAT), has resulted in the generation ... a genetic disease known as Fanconi anemia. The process ...
Cached Biology News:Simple drug treatment may prevent nicotine-induced SIDS: Study 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 2Researchers engineer metabolic pathway in mice to prevent diet-induced obesity 3Genetically corrected blood cells obtained from skin cells from Fanconi anemia patients 2